Histogenics Corp (HSGX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Histogenics Corp (HSGX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile


  • Products Id :- GDPH6500D
  • |
  • Pages: 37
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Histogenics Corp (Histogenics) is a regenerative medicine company that develops, markets and commercializes products for musculoskeletal disorders. The company provides product such as neocart, a tissue implant produced using a patient's own cartilage cells which are harvested from non-weight-bearing cartilage surface of the patient's femur. It offers products which are used to repair knee cartilage damage. Histogenics provides regenerative medicine platform that combines bioadhesives, cell processing, scaffolding, tissue engineering and growth factors to provide solutions for cartilage injuries associated with bone loss and arthritis. It also offers a platform for tissue repair solutions. Histogenics is headquartered in Waltham, Massachusetts, the US.

Histogenics Corp (HSGX)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Histogenics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Histogenics Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Histogenics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Histogenics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Histogenics Corp, Medical Devices Deals, 2012 to YTD 2018 9

Histogenics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Histogenics Corp, Pharmaceuticals & Healthcare, Deal Details 11

Licensing Agreements 11

Histogenics Amends Licensing Agreement With Purpose For NeoCart 11

Equity Offering 12

Histogenics Prices Public Offering of Shares and Warrants for USD17 Million 12

Histogenics Plans to Raise USD75 Million in Public Offering of Securities 14

Histogenics Raises USD6.3 Million in Public Offering of Shares 15

Histogenics Files Registration Statement for Public Offering of Shares to Raise USD50 Million 16

Histogenics Corp-Key Competitors 17

Histogenics Corp-Key Employees 18

Histogenics Corp-Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Recent Developments 20

Financial Announcements 20

Aug 09, 2018: Histogenics announces second quarter 2018 financial and operating results 20

May 10, 2018: Histogenics Announces First Quarter 2018 Financial and Operating Results 22

Mar 15, 2018: Histogenics Announces Financial and Operating Results for the Fourth Quarter and Year Ended December 31, 2017 23

Aug 10, 2017: Histogenics Announces Second Quarter 2017 Financial and Operating Results 26

May 11, 2017: Histogenics Announces First Quarter 2017 Financial and Operating Results 28

Mar 16, 2017: Histogenics Announces Financial and Operating Results for the Fourth Quarter and Year Ended December 31, 2016 29

Corporate Communications 31

Jul 31, 2018: Histogenics appoints E. Lynne Kelley, M.D., FACS as chief medical officer 31

Apr 18, 2018: Histogenics Appoints Susan Washer As Board Director 32

Oct 12, 2017: Histogenics Promotes Stephen Kennedy to Executive Vice President & Chief Operating Officer 33

Sep 18, 2017: Histogenics Announces Resignation of CMO 34

Jun 05, 2017: Histogenics Announces the Appointment of Donald Haut, Ph.D. as Chief Business Officer 35

Other Significant Developments 36

Feb 14, 2018: The Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Sixth Annual Cell & Gene Therapy Investor Day 36

Appendix 37

Methodology 37

About GlobalData 37

Contact Us 37

Disclaimer 37

List of Figures

Histogenics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Histogenics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Histogenics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Histogenics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Histogenics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Histogenics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Histogenics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Histogenics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Histogenics Corp, Medical Devices Deals, 2012 to YTD 2018 9

List of Tables

Histogenics Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Histogenics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Histogenics Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Histogenics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Histogenics Corp, Deals By Therapy Area, 2012 to YTD 2018 8

Histogenics Corp, Medical Devices Deals, 2012 to YTD 2018 9

Histogenics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Histogenics Amends Licensing Agreement With Purpose For NeoCart 11

Histogenics Prices Public Offering of Shares and Warrants for USD17 Million 12

Histogenics Plans to Raise USD75 Million in Public Offering of Securities 14

Histogenics Raises USD6.3 Million in Public Offering of Shares 15

Histogenics Files Registration Statement for Public Offering of Shares to Raise USD50 Million 16

Histogenics Corp, Key Competitors 17

Histogenics Corp, Key Employees 18

Histogenics Corp, Subsidiaries 19

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Histogenics Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17250
Site License
USD 500 INR 34500
Corporate User License
USD 750 INR 51750

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com